FDA embraces a new review process and approves SNM's multi-center IND for FLT
Reston, Va.SNM today announced FDA approval of an SNM-sponsored centralized multi-center investigational new drug (IND) application for 18F-labeled 3'-deoxy-3'-fluorothymidine (FLT).
The approval of multi-center Chemistry Manufacturing and Controls (CMC) in the FLT
IND represents the successful...
SNM's Clinical Trials Network expands European membership of PET biomarker manufacturers
...tion to obtain investigational imaging agents like flt
from a commercial provider instead of having to pr...vestigational new drug (IND) status for the use of flt
in multicenter studies. The goal of the network is...umber of sites that have access to biomarkers like flt
and may increase the number of sites able to parti...
Cancer research highlights
...different stages of their chemotherapy. They used a PET radio-tracer called flt
(fluoro-L-thymidine), which is readily taken up by cells during cell divisi...e leukemia cells divide more than normal cells, they should absorb a lot of flt
and appear brighter in the bone marrow of a PET scan. However, if chemother...
Siemens Showcases Innovative Leadership in Molecular Imaging at SNM 2008
...uorothymidine (F-18 FLT) imaging biomarker. The cross
reference allows F-18 flt
to be produced by Siemens/PETNET and used by any
principle investigator in ...e available to independent investigators if
they receive NCI approval. F-18 flt
is produced by Siemens Molecular
Imaging Biomarker Research and PETNET Solu...
Brain Tumor Patients Survival Depends on Predicting Treatment Responses Earlier
...hree months without treatment and up to a year with treatment," she said.
Using positron emission tomography (PET) imagingwith the radiotracer flt
(fluorothymidine)UCLA researchers were able to determine within one or two weeks after starting the treatment whether patients were responding well to...